Korean Skin Boosters Rejuran and Juvelook (2026): Mechanism, Protocols & International Patient Guide | Korean Plastic Surgery

Korean skin boosters Rejuran and Juvelook represent two of the most-searched injectables of 2026 for international patients seeking glassy skin and improved elasticity without obvious aesthetic change. Rejuran uses polynucleotides extracted from salmon DNA to stimulate fibroblast activity and skin repair, while Juvelook combines PDLLA microspheres with hyaluronic acid for biostimulation and immediate volumization. This 2026 guide helps international patients understand mechanism, indications, scheduling, and 2026 protocol updates at Seoul clinics.

How Korean dermatologists frame the choice in 2026

Korean dermatology has refined skin booster protocols significantly through 2026, with most major Seoul clinics now offering combined Rejuran + Juvelook regimens for patients seeking both repair and structural support. Rejuran is typically positioned as a barrier-repair and pore-tightening agent, while Juvelook delivers volumetric biostimulation with longer-lasting collagen induction. KSPRS aesthetic dermatology data for 2025-2026 indicates skin booster injectables now represent approximately 30% of dermatology injection volume in Korea, up from 18% in 2023.

Dermatologists assess skin barrier function, dermal thickness via ultrasound, and patient goals during 20-30 minute consultations. International patients should request before-after photography under standardized lighting to objectively measure outcomes.

Rejuran: mechanism and 2026 protocols

Rejuran (PN polynucleotides) stimulates fibroblast activity through pattern recognition receptors, accelerating dermal repair and reducing inflammation. The current 2026 protocol in most Seoul clinics is 3-4 sessions spaced 3-4 weeks apart, with maintenance sessions every 4-6 months. Visible glow typically appears after session 2.

Indications include rough texture, post-acne marks, mild scarring, periocular fine lines (Rejuran Eye variant), and barrier-compromised skin. Most patients return to normal activities within 24 hours. Common transient side effects include injection-site swelling and small papules for 2-3 days.

Juvelook: mechanism and 2026 protocols

Juvelook combines PDLLA (poly-D,L-lactic acid) microspheres with cross-linked hyaluronic acid, delivering immediate volumization through HA and longer-term collagen stimulation through PDLLA biodegradation over 12-18 months. The 2026 standard protocol in Seoul clinics is 2-3 sessions spaced 4-6 weeks apart, with maintenance every 12-18 months.

Indications include skin laxity, structural support deficits, deeper texture issues, and patients seeking longer-lasting results than pure HA boosters provide. Most patients return to normal activities within 24-48 hours. Transient injection-site swelling typically resolves within 3-5 days.

Decision factors international patients often miss in 2026

Four practical factors matter beyond mechanism: first, series planning — both products require multiple sessions, often necessitating return trips or extended Korea stays; second, photographic baseline matters because results are subtle and easy to miss without standardized lighting; third, 2026 supply chain — both products have experienced periodic supply constraints, so confirm product availability and lot authenticity before traveling; fourth, language barrier for treatment planning, especially when combining products.

Cost ranges and what is bundled in 2026

Published Korean clinic ranges in early 2026 placed Rejuran at 250-450K KRW per session and Juvelook at 350-650K KRW per session, varying by clinic district and bundled services. Combined-protocol packages typically run 1.8-3.2 million KRW for a complete series. International patient packages often bundle interpreter services, post-injection skincare, and one follow-up visit.

Risk profile and side effects

Both products share core risks: injection-site bruising, swelling, redness, small papules, and rarely infection. Juvelook adds rare risk of nodule formation if injection technique is suboptimal, requiring product massage and occasional steroid injection for resolution. Both products have established Korean MFDS approval and are widely distributed through authorized channels.

Korea-specific quality checks for 2026

Verify product authenticity through MFDS-registered importer chains. Reputable Seoul clinics will show product packaging, lot numbers, and importer documentation on request. Counterfeit skin boosters have been a documented problem in 2024-2026 — never accept products without official packaging.

Can I combine Rejuran and Juvelook in 2026?

Yes. Most Seoul clinics now offer combined protocols where Rejuran addresses surface texture and barrier function while Juvelook provides structural support. Sessions are typically alternated 3-4 weeks apart, requiring 6-8 total visits for a comprehensive series.

How soon will I see results?

Subtle glow and texture improvement typically appears after session 2 (4-8 weeks from start). Maximum results stabilize 3-4 months after the last session. Juvelook structural effects continue developing over 12-18 months as PDLLA stimulates collagen.

How long do results last?

Rejuran results typically last 4-6 months before maintenance is needed. Juvelook structural effects last 12-18 months due to longer PDLLA biodegradation. Maintenance protocols vary by individual collagen response and lifestyle factors.

What is the minimum stay in Korea?

A single session requires only 1-2 days. Full series typically requires either return trips at 3-6 week intervals or an extended 6-8 week stay. International patients should plan series timing around travel logistics.

Bottom line for 2026

Rejuran and Juvelook represent the 2026 standard for natural-looking skin enhancement in Korea, with combined protocols becoming the dominant approach for comprehensive results. Both should only be administered by board-certified dermatologists at KHIDI-listed Seoul clinics using MFDS-authenticated products. Book a virtual consultation with skin imaging to receive 2026 protocol recommendations before traveling.

Related Reading

How Pico Laser Actually Works · Korean Exosome Therapy for Skin · Botox vs Filler for Anti-Aging Decision Framework

Sources

Authoritative sources cited in this guide: KHIDI Medical Tourism · KSPRS Korean Society for Aesthetic Plastic Surgery · PubMed peer-reviewed literature

Medical Review

Last medically reviewed: 2026-05-29. All content reflects current Korean clinical practice and peer-reviewed literature as of the review date. Procedures should always be discussed with a board-certified medical professional at a KHIDI-accredited Korean clinic before booking.